This article is more than 5 years old. Information may no longer be current.

Insulin pens with new delivery system receive FDA approval

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA recently approved two Novo Nordisk prefilled insulin pens — NovoLog and Levemir — that utilize the new FlexTouch injection system, according to a press release.

The company announced the approval and said the FlexTouch system implemented on both pens will help patients better administer their medications.

“When a dose is dialed with traditional prefilled pens, the push button extends, and at larger doses this can present challenges for the patient. The unique dosing mechanism of FlexTouch ensures the push-button does not extend at any dose and allows insulin to be administered by pressing the low dose force button,” according to the press release.

The system was approved by the European Commission in July 2011 and should be available in the US within the next year.

NovoLog FlexTouch contains 300 units of insulin aspart and doses in 1 unit increments, from 1 to 80 units. Levemir FlexTouch contains 300 units of insulin detemir and also doses in 1 unit increments, from 1 to 80 units.